 WON-SALEM, N.C., Dec. 22, 2022 GLOBE NEWSWIRE -- ProKidney Corp. Nasdaq: PROK ProKidney, a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease CKD, today announced that Dr. Tim Bertram, Chief Executive Officer, will present at the J.P. Morgan 41st Annual Healthcare Conference in San Francisco on Wednesday, January 11th, 2023, at 3:45 PM PT. 